Abstract. This is an initial report of a new method of axillary dissection via a periareolar incision and an 8 mm incision in the axilla with the da Vinci Surgical System. The 10 magnification and three-dimensional image, together with the versatility and precision of the robotic telemanipulators, has enabled us to perform nerve-sparing axillary dissection in four patients with invasive ductal carcinoma of the breast undergoing segmental (conservative) excision and level II axillary dissection. The time for the robotic axillary dissection ranged from 30 to 105 minutes (average 70.5 minutes). The average number of lymph nodes retrieved was 13 (11, 11, 13, and 17, respectively). Postoperatively all four patients recovered well and were discharged the next day. The robotic system can enhance the surgeonÕs ability by providing a high-definition, magnified, three-dimensional view of the operative field, intuitively controlled articulating instruments, and elimination of tremors; and it has potential benefits for the patient.
For women with invasive breast cancer, the status of axillary node involvement is the single best predictor of survival, and important treatment decisions are based on this information [1, 2] . Whereas much progress and innovation has been made in the surgical approaches to the breast [3] , there has been little progress made in the surgical approach to the axilla. For women with breast cancer, the presence of metastatic disease in the regional basin significantly decreases the 5-year survival [4] . A level I and II axillary dissection is recommended for staging purposes as well as for local control [5] . However, axillary dissection has been associated with significant morbidity, including pain, paresthesia, swelling, shoulder dysfunction, and lymphedema. Multiple reports have shown that axillary dissection was associated with a 60% chance of paresthesia, pain in 45%, weakness in 40%, swelling in 26%, stiffness in 12%, and lymphedema in up to 43% [6, 7] .
The logical step in the advancement of breast cancer surgery would be to decrease the morbidity associated with axillary dissection without necessarily sacrificing lymph node retrieval for accurate staging. Less invasive treatment modalities have been evaluated to lower the morbidity of axillary lymph node dissection. These have included the sentinel lymph node biopsy [8, 9] (SLNB) and endoscopic axillary lymph node dissection [10] [11] [12] [13] [14] . SLNB in particular is rapidly being accepted by many centres as a low morbidity method of identifying possible spread to the axilla.
Since March 2003, we have performed laparoscopic axillary dissection in patients with breast cancer and have noted significant patient benefits in terms of less pain and paresthesia as well as improved shoulder mobility. However, the procedure itself is cumbersome and nonergonomic, given the reduced range of motion and instrument dexterity, and the two-dimensional view of the operative field.
In recent years, there have been rapid advances in the surgical procedures performed using the da Vinci Surgical System (Intuitive Surgical, Sunnyvale, CA, USA) [15] [16] [17] [18] . The system uses a master-slave robot concept where the surgeon controls telemanipulators to perform the operation-hence the commonly used term ''robotic surgery.'' The advantages of robotic surgery using this system include magnification of 10, elimination of tremor, three-dimension (3-D) vision, use of instruments with 7 degrees freedom of movement, and that the surgeon can perform the procedure comfortably seated with an armrest for support. Procedures demanding superior visualization or requiring complex reconstruction obtain the greatest benefit from robotics over conventional laparoscopy. This is an initial report of four patients with invasive ductal carcinoma of the breast who underwent axillary dissection using the da Vinci Surgical System. The objective was to develop a technique of nerve-sparing robotic axillary dissection for patients with breast cancer. To our knowledge, this is the first such report in the medical literature.
Patients and Methods
Between November 3 and November 25 2004, four robotic axillary dissection were successfully performed on four patients with T1 and T2 infiltrating ductal carcinoma of the breast who underwent segmental excision using the da Vinci Surgical System. All patients were comprehensively informed about the technique and signed informed consent. The age range was 45 to 60 years. The tumor size ranged from 0.9 to 3.0 cm. The tumor location was in the upper, outer quadrant (two patients), upper inner quadrant (one patient), and lower outer quadrant (one patient).
Correspondence to: Susan M.L. Lim, FRCS, Ph.D., e-mail: sl@ susanlimsurgery.com General anesthesia with endotracheal intubation was employed, and the patient was positioned supine with the arm abducted to 120 degrees. A large, soft roll was positioned under the side of the patient to elevate that side from the table 30 degrees. Segmental excision of the tumor was first performed through a periareolar incision. Following excision of the tumor with clear margins, the breast cavity was washed with saline, and hemostasis was achieved prior to commencing the axillary dissection.
The axillary space was created as follows: The clavipectoralaxillary fascia was gently opened by blunt dissection and a ''closed-open'' scissor dissection performed gently into the axillary space through the opening. This opening provided the working space and access to the axilla for the endoscope and instrument arm of the surgical system.
The surgical cart of the da Vinci Surgical System containing the camera arm and the left and right instrument arms was positioned over the shoulder. A 0 degree, 3D endoscope (InSite Vision System; Intuitive Surgical) was placed through the periareolar incision and targeted toward the axillary vein (Fig. 1) . Bipolar coagulating forceps, placed in the arm of the robot, was also positioned through the same incision. A cautery hook (two patients) or cautery spade (two patients) connected to unipolar diathermy was placed in the contralateral arm of the robot and inserted through an 8 mm incision in the axilla. A self-retaining retractor was placed in the incision to maintain the axillary space.
The dissection was commenced medially. The medial pectoral nerve branches to pectoralis major were identified and preserved. The dissection was continued deep to the pectoralis major, sweeping RotterÕs interpectoral nodes laterally. Near the apex of the axilla, the adipose tissue was dissected and swept from the undersurface of the pectoralis minor, clearing level II nodes up to the medial border of the pectoralis minor. Superiorly, the dissection was commenced from the lower border of the axillary vein, with care taken to preserve the adventitia surrounding the vein. The axillary adipose tissue was swept laterally from the chest wall and inferiorly from the axillary vein. The intercostobrachiocutaneous nerve was identified as it emerged from the serratus anterior and coursed through the axillary fat pad toward the upper inner arm; it was carefully preserved. In three patients, a second intercostal sensory branch was observed crossing the axilla and preserved. The long thoracic nerve was identified and preserved as it descended vertically along the chest wall to innervate the serratus anterior muscle. Lymph node-bearing tissue was swept inferiorly and laterally along the chest wall. The thoracodorsal nerve and the subscapular artery and vein, lying on the anterior surface of subscapularis muscle, were identified and preserved. Once all three nerves had been identified and dissected free from the axillary contents, the axillary fat pad was dissected in a lateral and inferior direction to the anterior border of the latissimus dorsi muscle and divided. Hemostasis was achieved with unipolar or bipolar coagulation.
The specimen and lymph nodes contained within were extracted through the breast incision and submitted to pathology. The breast incision was closed with 4/0 Vicryl and Steri-Strips. No surgical drainage was required for the axilla. The stab incision in the axilla was closed with a Steri-Strip. All patients were admitted overnight following surgery and discharged the next day.
Results
Four patients underwent robotic axillary dissection following segmental excision for invasive ductal carcinoma of the breast. The setup times for the da Vinci system ranged from 8 to 15 minutes, the mean operative duration for the robotic axillary dissection was 70.5 minutes (30, 72, 75, and 105 minutes, respectively), and the mean total operating time for both the breast and axillary surgery (measured from the time of the initial skin incision to when the last subcutaneous stitch was completed) was 164 minutes (range 130-200 minutes). There were no major intraoperative technical failures of the da Vinci telemanipulator system. Blood loss was negligible in all four cases. The margins of resection of the breast tissue were free of tumor in all patients. The average number of lymph nodes removed was 13 (11, 11, 13, 17, respectively) . The average number of lymph nodes involved was 5 (2, 4, 7, 7). All patients were hospitalized for one night following surgery and discharged the following day. There were no intra-or postoperative complications such as hematoma, wound infection, or injury to nerves and vessels. Axillary pain, seroma formation, and sensitivity effects were minimal, with the major advantage, often realized by the patient and surgeon immediately after surgery, being the significant improvement in mobility of the operated arm, with full range of movement.
Discussion
Improved surgical techniques in breast cancer surgery have evolved over the years, which include skin-and areolar-sparing mastectomy, segmental mastectomy, oncoplastic breast procedures, and reconstructive options [19] [20] [21] . This increased use of breast-conserving therapy for treatment of breast cancer has nearly eliminated the major morbidity of loss of the breast. The present focus of postoperative morbidity has shifted to the axillary dissection, a procedure which for many women has become the major cause of long-term morbidity after local therapy for breast cancer [22] .
In the surgical approach to the axilla, however, apart from the sentinel node biopsy, there have been few innovations in techniques to spare the common complications of an axillary dissection, which range from seroma or hematoma formation to injury to the nerves that course through the axilla. Injury to the long thoracic nerve may result in a winged scapula or palsy of the serratus anterior muscle and may occur in up to 10% of cases, [23] . Injury to the thoracodorsal nerve leads to weakness of the latissimus dorsi muscle. Injury to the intercostobrachial nerve may cause permanent numbness in the lateral axilla and medial portion of the upper arm. These injuries, distressing to patients, are probably underestimated, as they are not life-threatening and do not require hospitalizationl [24] .
In this initial report, we have shown that axillary lymph node dissection with the da Vinci Surgical System is a precise, gentle, safe alternative to lymphadenectomy performed via a standard axillary incision. The authors embarked on this technique after realizing provided that the robotic approach provided a better precision and visualization, which could result in less morbidity after axillary dissection. This ergonomic master-slave system offered3-D visualization, wristed instrumentation, intuitive fingercontrolled movements and a comfortable seated position for the surgeon. The increase in operating time reflects the initial small learning curve; however, the advantages of dissection using telemanipulators were striking to the surgeon and appeared to have a significant impact on patient outcome. Surgeon advantages included a 3D view of the axilla, 10 magnification, and an ergonomic operating position with 7 degrees of freedom movement of the instruments with elimination of tremor. Potential disadvantages of this technology are the added cost and the lack of tactile sensation, but 3-D visualization compensated for this latter handicap. Patient outcome may be improved as the enhanced view facilitates identification and preservation of the nerves in the axilla: the long thoracic nerve on the medial wall, the thoracodorsal nerve on the posterior wall, and the intercostobrachial nerves. In addition, lymph nodes and lymphatic channels are better visualized, adding to the completeness of the lymphatic dissection. The reason for the minimal seroma is probably the better visualization and more meticulous and precise dissection using a ''no-touch'' technique; that is, the tissues were handled only using the robotic instruments. In all four patients, oncologic standards were achieved with a minimum retrieval of 10 lymph nodes. The aesthetic result was also better, as a separate axilla incision was avoided. To our knowledge, this is the first report of axillary dissection of level I and II lymph nodes using the da Vinci Surgical System. Sentinel lymph node biopsy remains an excellent management option with low morbidity. We believe that robotic axillary dissection is a useful complement to this technique when there is a need for complete axillary dissection. There are distinct advantages with robotic axillary dissection, and it can be added to the repertoire of procedures in a hospital that has purchased the robot for use during other types of surgery.
Conclusions
Nerve-sparing axillary dissection with the da Vinci Surgical System is feasible and can be performed within the current oncologic standards. Access to the axillary space is obtained through the initial incision for breast tumor removal and eliminates the need for a second main axillary incision. The 3-D view, magnified 10, and the robotic telemanipulators can enhance the surgeonÕs ability with better vision, intuitive instrument control and depth perception, and elimination of tremors; and it can possibly reduce postoperative complications for the patient. We conclude that robotic axillary lymph node dissection can be safely introduced into a breast cancer surgery program.
